146 related articles for article (PubMed ID: 32201147)
1. Laser-Based Devices for Female Genitourinary Indications: Position Statements From the European Society for Sexual Medicine (ESSM).
Romero-Otero J; Lauterbach R; Aversa A; Serefoglu EC; García-Gómez B; Parnham A; Skrodzka M; Krychman M; Reisman Y; Corona G; Lowenstein L
J Sex Med; 2020 May; 17(5):841-848. PubMed ID: 32201147
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency-Based Devices for Female Genito-Urinary Indications: Position Statements From the European Society of Sexual Medicine.
Romero-Otero J; Lauterbach R; Aversa A; Serefoglu EC; García-Gómez B; Parnhan A; Skrodzka M; Krychman M; Reisman Y; Corona G; Lowenstein L
J Sex Med; 2020 Mar; 17(3):393-399. PubMed ID: 32129169
[TBL] [Abstract][Full Text] [Related]
3. IUGA committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity.
Shobeiri SA; Kerkhof MH; Minassian VA; Bazi T;
Int Urogynecol J; 2019 Mar; 30(3):371-376. PubMed ID: 30523374
[TBL] [Abstract][Full Text] [Related]
4. Lasers and energy-based devices marketed for vaginal rejuvenation: A cross-sectional analysis of the MAUDE database.
Ahluwalia J; Avram MM; Ortiz AE
Lasers Surg Med; 2019 Oct; 51(8):671-677. PubMed ID: 30924953
[TBL] [Abstract][Full Text] [Related]
5. Lasers in gynaecology.
Phillips C; Hillard T; Salvatore S; Toozs-Hobson P; Cardozo L
Eur J Obstet Gynecol Reprod Biol; 2020 Aug; 251():146-155. PubMed ID: 32505055
[TBL] [Abstract][Full Text] [Related]
6. Update: The Clinical Role of Vaginal Lasers for the Treatment of the Genitourinary Syndrome of Menopause.
Mounir DM; Hernandez N; Gonzalez RR
Urology; 2021 May; 151():2-7. PubMed ID: 32966821
[TBL] [Abstract][Full Text] [Related]
7. The energy based devices for vaginal "rejuvenation," urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: An international multidisciplinary expert panel opinion.
Digesu GA; Tailor V; Preti M; Vieira-Baptista P; Tarcan T; Stockdale C; Mourad S
Neurourol Urodyn; 2019 Mar; 38(3):1005-1008. PubMed ID: 30697814
[TBL] [Abstract][Full Text] [Related]
8. Applicability of vaginal energy-based devices in urogynecology: evidence and controversy.
Machado AC; Judice LMDPP; Riccetto CLZ; Toledo LGM
Rev Assoc Med Bras (1992); 2023; 69(suppl 1):e2023S129. PubMed ID: 37556648
[TBL] [Abstract][Full Text] [Related]
9. Vaginal laser treatment of genitourinary syndrome of menopause: does the evidence support the FDA safety communication?
Guo JZ; Souders C; McClelland L; Anger JT; Scott VCS; Eilber KS; Ackerman AL
Menopause; 2020 Oct; 27(10):1177-1184. PubMed ID: 32796292
[TBL] [Abstract][Full Text] [Related]
10. In response to the FDA warning about the use of photomedicine in gynecology.
Escribano JJ; González-Isaza P; Tserotas K; Athanasiou S; Zerbinati N; Leibaschoff G; Salvatore S; Sánchez-Borrego R
Lasers Med Sci; 2019 Sep; 34(7):1509-1511. PubMed ID: 30830556
[TBL] [Abstract][Full Text] [Related]
11. Lasers in the era of evidence-based medicine.
Hillard TC
Climacteric; 2020; 23(sup1):S6-S10. PubMed ID: 33124459
[TBL] [Abstract][Full Text] [Related]
12. Hormonal Contraception and Female Sexuality: Position Statements from the European Society of Sexual Medicine (ESSM).
Both S; Lew-Starowicz M; Luria M; Sartorius G; Maseroli E; Tripodi F; Lowenstein L; Nappi RE; Corona G; Reisman Y; Vignozzi L
J Sex Med; 2019 Nov; 16(11):1681-1695. PubMed ID: 31521571
[TBL] [Abstract][Full Text] [Related]
13. The clinical role of LASER for vulvar and vaginal treatments in gynecology and female urology: An ICS/ISSVD best practice consensus document.
Preti M; Vieira-Baptista P; Digesu GA; Bretschneider CE; Damaser M; Demirkesen O; Heller DS; Mangir N; Marchitelli C; Mourad S; Moyal-Barracco M; Peremateu S; Tailor V; Tarcan T; De EJB; Stockdale CK
Neurourol Urodyn; 2019 Mar; 38(3):1009-1023. PubMed ID: 30742321
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design for fractional microablative CO
Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S
Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause.
Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M
Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235
[TBL] [Abstract][Full Text] [Related]
16. Low-Intensity Shock Wave Therapy in Sexual Medicine-Clinical Recommendations from the European Society of Sexual Medicine (ESSM).
Capogrosso P; Frey A; Jensen CFS; Rastrelli G; Russo GI; Torremade J; Albersen M; Gruenwald I; Reisman Y; Corona G
J Sex Med; 2019 Oct; 16(10):1490-1505. PubMed ID: 31447380
[TBL] [Abstract][Full Text] [Related]
17. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO
Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M
Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942
[TBL] [Abstract][Full Text] [Related]
18. [Vaginal laser therapy for urinary incontinence and genitourinary syndrome of menopause : A review].
Ratz C
Urologe A; 2019 Mar; 58(3):284-290. PubMed ID: 30721329
[TBL] [Abstract][Full Text] [Related]
19. [CO
Jardin I; Canlorbe G; Mergui JL; Nikpayam M; Belghiti J; Uzan C; Azaïs H
Gynecol Obstet Fertil Senol; 2018 Nov; 46(10-11):729-734. PubMed ID: 30241737
[TBL] [Abstract][Full Text] [Related]
20. Laser therapy for the restoration of vaginal function.
Gambacciani M; Palacios S
Maturitas; 2017 May; 99():10-15. PubMed ID: 28364861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
